Back to home

Product info

October 2020/RESP-764



Full prescribing information available here


MAY 2021 / RESP-330b(3)


Adverse events should be reported. Reporting forms and information can be found at Adverse events should also be reported to Orion Pharma (UK) Ltd on 01635 520300.

Orion Pharma (UK) Ltd, Abbey Gardens, 4 Abbey Street, Reading, RG1 3BA, UK | Tel: +44 1635 520 300 | February 2021 / RESP-330(1)
Policies Contact us Orion Corporation 2021